Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 42 of 1,261
  1. US 12304942

    Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

    AUTOLUS LIMITED · Granted May 20, 2025 · Expires May 15, 2045

    granted
  2. US 12304940

    HLA class II-restricted t cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 20, 2025 · Expires May 15, 2045

    granted
  3. US 12303618

    Oxygen-generating cryogels

    Northwestern University · Granted May 20, 2025 · Expires May 15, 2045

    granted
  4. US 12304901

    Selective ligands for tau aggregates

    Sentonix, Inc. · Granted May 20, 2025 · Expires May 15, 2045

    granted
  5. US 12304900

    Islet cell manufacturing compositions and methods of use

    Vertex Pharmaceuticals Incorporated · Granted May 20, 2025 · Expires May 15, 2045

    granted
  6. US 12303481

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Granted May 20, 2025 · Expires May 15, 2045

    granted
  7. US 12303594

    Antimicrobial and anti-inflammatory compositions

    The Board of Regents of the University of Texas System · Granted May 20, 2025 · Expires May 15, 2045

    granted
  8. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    CRISPR THERAPEUTICS AG · Granted May 20, 2025 · Expires May 15, 2045

    granted
  9. US 12297202

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  10. US 12296025

    AAV capsid variants and uses thereof

    VOYAGER THERAPEUTICS, INC. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  11. US 12296047

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  12. US 12295971

    Compositions and methods for enhancing adoptive T cell therapeutics

    The Regents of the University of California · Granted May 13, 2025 · Expires May 8, 2045

    granted
  13. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  14. US 12295941

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited · Granted May 13, 2025 · Expires May 8, 2045

    granted
  15. US 12296004

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 13, 2025 · Expires May 8, 2045

    granted
  16. US 12297186

    Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

    AGOMAB SPAIN, S.L.U. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  17. US 12297182

    Compositions comprising an urolithin compound

    Amazentis SA · Granted May 13, 2025 · Expires May 8, 2045

    granted
  18. US 12297243

    Methods and compositions for reducing the immunogenicity of chimeric notch receptors

    Cell Design Labs, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  19. US 12295929

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted May 13, 2025 · Expires May 8, 2045

    granted
  20. US 12297259

    Aspergillus antigen chimeric receptors and use thereof

    The Board of Regents of the University of Texas System · Granted May 13, 2025 · Expires May 8, 2045

    granted
  21. US 12297257

    Multispecific antigen-binding molecules and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  22. US 12296066

    Methods of wound healing with Serp-1 polypeptides

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 13, 2025 · Expires May 8, 2045

    granted
  23. US 12297447

    Gene therapy for juvenile Batten disease

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 13, 2025 · Expires May 8, 2045

    granted
  24. US 12295931

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Granted May 13, 2025 · Expires May 8, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.